Report Detail
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Insights, Forecast to 2025
- RnM2953561 |
- 16 February, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Other
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.
ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.
North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.
Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market is valued at 130 million US$ in 2018 and will reach 260 million US$ by the end of 2025, growing at a CAGR of 8.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the ICAD (Intracranial Atherosclerotic Disease) Pathology market based on company, product type, end user and key regions.
This report studies the global market size of ICAD (Intracranial Atherosclerotic Disease) Pathology in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of ICAD (Intracranial Atherosclerotic Disease) Pathology in these regions.
This research report categorizes the global ICAD (Intracranial Atherosclerotic Disease) Pathology market by top players/brands, region, type and end user. This report also studies the global ICAD (Intracranial Atherosclerotic Disease) Pathology market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Stryker
Balt
TERUMO
MicroPort
Acandis
Market size by Product
primarily split into
Stent
PTA Balloon
Market size by End User
Hospital
Clinic
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global ICAD (Intracranial Atherosclerotic Disease) Pathology market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of ICAD (Intracranial Atherosclerotic Disease) Pathology market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global ICAD (Intracranial Atherosclerotic Disease) Pathology companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of ICAD (Intracranial Atherosclerotic Disease) Pathology submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of ICAD (Intracranial Atherosclerotic Disease) Pathology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of ICAD (Intracranial Atherosclerotic Disease) Pathology market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Product
- 1.4.2 primarily split into
- 1.4.3 Stent
- 1.4.4 PTA Balloon
- 1.5 Market by End User
- 1.5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size
- 2.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2014-2025
- 2.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2014-2025
- 2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Growth Rate by Regions
- 2.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Regions
- 2.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers
- 3.1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers
- 3.1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturers
- 3.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Ratio (CR5 and HHI)
- 3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers
- 3.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2014-2019)
- 3.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers (2014-2019)
- 3.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturers
- 3.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution, Product Types
- 3.4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
- 3.4.3 Date of International Manufacturers Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product
- 4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Product
- 4.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Breakdown Data by End User
6 North America
- 6.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries
- 6.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries
- 6.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology by Product
- 6.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology by End User
7 Europe
- 7.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries
- 7.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries
- 7.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Product
- 7.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by End User
8 Asia Pacific
- 8.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries
- 8.1.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries
- 8.1.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology by Product
- 8.3 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology by End User
9 Central & South America
- 9.1 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries
- 9.1.1 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries
- 9.1.2 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology by Product
- 9.3 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology by End User
10 Middle East and Africa
- 10.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries
- 10.1.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries
- 10.1.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Product
- 10.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by End User
11 Company Profiles
- 11.1 Stryker
- 11.1.1 Stryker Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
- 11.1.5 Stryker Recent Development
- 11.2 Balt
- 11.2.1 Balt Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
- 11.2.5 Balt Recent Development
- 11.3 TERUMO
- 11.3.1 TERUMO Company Details
- 11.3.2 Company Business Overview
- 11.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
- 11.3.5 TERUMO Recent Development
- 11.4 MicroPort
- 11.4.1 MicroPort Company Details
- 11.4.2 Company Business Overview
- 11.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
- 11.4.5 MicroPort Recent Development
- 11.5 Acandis
- 11.5.1 Acandis Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
- 11.5.5 Acandis Recent Development
12 Future Forecast
- 12.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Regions
- 12.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Regions 2019-2025
- 12.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Regions 2019-2025
- 12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Product
- 12.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Product 2019-2025
- 12.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Product 2019-2025
- 12.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by End User
- 12.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast
- 12.5 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast
- 12.6 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast
- 12.7 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast
- 12.8 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on ICAD (Intracranial Atherosclerotic Disease) Pathology . Industry analysis & Market Report on ICAD (Intracranial Atherosclerotic Disease) Pathology is a syndicated market report, published as Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
